Red Chip Enterprises Launches In-House Dispensing Pharmacy in Support of Hemophilia Treatment Centers Utilizing Red Chip’s Suite of 340B Management Services
Irvine, California, March 16, 2015 — Red Chip Enterprises (RCE) announced today the addition of its new in-house pharmacy to benefit Hemophilia Treatment Center (HTC) clients receiving outpatient factor products and ancillaries under the 340B Federal Drug Discount Program. RCE is the leading provider of bleeding disorder related 340B management services nationwide, will soon serve all 50 states and now provides 24/7 access to its own licensed pharmacist.
“I’m very pleased to offer pharmacy services to our HTC clients and the patients they serve,” said pharmacy manager Vishal Gandhi, Pharm.D, RPh. “We can now process verbal prescriptions telephonically, decrease delivery times, and handle emergency requests. The new pharmacy also allows us to deliver specialized dispensing and offer data collection services as a contracted pharmacy partner.”
Red Chip Enterprises has been providing 340B management services to Hemophilia Treatment Centers since 2001. Currently serving 17 Centers, Red Chip has partnered with clients to grow their outpatient factor programs and does not operate as a specialty pharmacy or compete in any way with an HTC’s own factor program.
Serving the hemophilia community for over 30 years, Red Chip’s management executives were the co-founders of Quantum Health Resources prior to the founding of Red Chip. Ther experience and expertise is unmatched in the design and implementation of HTC outpatient factor programs. Each program is tailored to specific client requirements and includes payer marketing, customer service, product ordering, warehousing, shipping and tracking. In addition, billing, collecting and producing a full suite of financial reports are standard program features.
Contact Kellen Yamaguchi or Mary Ann Barth at 949-223-9828 for more information.